Endre is a senior epidemiologist with strong clinical and academic background recognized for leading innovative and high-quality research using synthesized evidence to characterize the safety and effectiveness of a wide variety of therapeutics. He has extensive experience leading safety, effectiveness, drug utilization, and validation studies for oncology, biosimilars, rare disease, cardiovascular, respiratory, and neuroscience therapeutics in the US and Europe. He has a deep understanding of real-world evidence from data generation, integration, and analysis to interpretation. Endre has unique expertise with machine learning-supported evidence synthesis and meta-analysis platforms.